Latest News

Pilgrim's Pride (PPC) has recently attracted investor attention after its shares closed at US$40.41. This has prompted a closer look at how the company’s current valuation lines up with its recent financial profile. See our latest analysis for Pilgrim's Pride. That US$40.41 share price comes after a 7-day share price return of 7.62% and a 90-day share price return of 5.95%, while the 5-year total shareholder return of 146.27% points to a much stronger long-run journey. If Pilgrim’s Pride has...

In early January 2026, ADMA Biologics raised its preliminary 2025 and 2026 revenue guidance to about US$510–US$511 million and US$635 million, respectively, while also issuing new long-range revenue targets of roughly US$775 million for 2027 and more than US$1.10 billion for 2029. The company also highlighted yield-enhanced production, plasma network repositioning, and progress on its SG-001 program as levers to support margin expansion, supply security, and future product...

If you are wondering whether CompoSecure shares still offer value after recent attention, this article walks through what the current price might be implying about the business. The stock last closed at US$21.43, with total returns of 7.8% over 7 days, 6.0% over 30 days, 14.8% year to date, 83.0% over 1 year and a very large gain over 3 years that is around 4x, plus 157.6% over 5 years. Recent coverage has focused on CompoSecure's role in payment card and security products, along with how...

Earlier this month, IREN Limited filed a shelf registration for approximately US$661.0 million covering 17,500,000 ordinary shares in an ESOP-related offering, while advancing its shift from Bitcoin mining toward AI cloud infrastructure under a multi‑year AI data center contract with Microsoft. This combination of fresh equity capacity and a large, long-term hyperscaler agreement underlines how IREN is funding and scaling its move into high-performance AI compute services alongside its...

In early January 2026, Abbott Laboratories launched Libre Assist, a new generative AI feature within its Libre app that helps people with diabetes in the U.S. predict how specific foods may affect their glucose levels and then compares those predictions with post-meal data from Libre continuous glucose monitoring sensors. This move highlights Abbott’s push to integrate AI-driven decision support directly into everyday diabetes management, potentially deepening user engagement with the...

If you are wondering whether Compañía de Minas BuenaventuraA’s recent share price puts it on the expensive side or still leaves room for value, you are not alone. The stock last closed at US$34.34, with returns of 13.9% over 7 days, 21.9% over 30 days, 20.1% year to date and 175.5% over the past year, as well as 353.9% over 3 years and 230.1% over 5 years. Investors have been reacting to ongoing market interest in metals and mining companies and shifting sentiment toward producers with...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Robust financial results put Sezzle (SEZL) in focus Recent attention around Sezzle (SEZL) centers on its strong financial results, where revenue growth has been paired with even faster earnings expansion. This combination signals efficient scaling and sharpened profitability. See our latest analysis for Sezzle. Sezzle’s shares now trade at US$76.26. Even with a 2.2% decline in the 3 month share price return, the 7 day share price return of 6.26% and the year to date share price return of...

In the past few days, Jefferies analyst Mitch Ryan downgraded 29Metals to Underperform after the company reported an 86% zinc production shortfall in the fourth quarter due to seismic issues at its Xantho Extended mine. This combination of a sharply weaker operating outcome and a more cautious analyst stance has intensified focus on 29Metals’ ability to deliver on its longer-term production plans. We’ll now examine how the Xantho Extended seismic disruption and resulting production shortfall...

If you are wondering whether Novo Nordisk is fairly priced or if the recent buzz has pushed it too far, this article walks through what the numbers actually say about the stock. Over the past week the share price moved 6.0%, over 30 days it was 18.9%, year to date it is 13.8%, while the 1 year and 3 year returns are 25.1% and 11.0% declines, compared to a 73.6% gain over 5 years. Recent headlines have kept Novo Nordisk in the spotlight, with ongoing attention on its role in treatments that...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

If you are wondering whether Agnico Eagle Mines is priced attractively after a big run, this article will walk through what the current share price might be implying about value. The stock last closed at US$199.08, with returns of 10.2% over 7 days, 18.3% over 30 days, 16.8% year to date and 140.2% over the past year; recent price action has been very strong. Recent headlines around Agnico Eagle Mines have focused on broader interest in gold related equities and ongoing attention on miners...

Meituan (SEHK:3690) remains in focus for investors who are watching how its recent share performance lines up with the company’s current fundamentals, including revenue, earnings, and return figures over different time frames. See our latest analysis for Meituan. At a share price of HK$104.9, Meituan’s recent 30 day and 90 day share price returns of 2.44% and 5.00% suggest modest positive momentum. However, the 1 year total shareholder return of a 27.30% decline points to a weaker longer term...

Heineken N.V. recently announced that CEO and Executive Board Chairman Dolf van den Brink will step down on 31 May 2026 after almost six years in the role, remaining in an advisory capacity for eight months from 1 June 2026 to support the transition. His planned departure comes shortly after Heineken set its EverGreen 2030 strategy and executed a US$3.20 billion acquisition in Central America, meaning new leadership will inherit an already reshaped portfolio and long-term plan. With Dolf van...

If you are wondering whether Realty Income is priced attractively right now, this article will walk through what the current share price could mean for long term investors. The stock closed at US$59.23 most recently, with returns of 3.2% over the last 7 days, 2.6% over 30 days, 3.4% year to date, 17.9% over 1 year, 4.5% over 3 years and 35.3% over 5 years. Recent coverage has focused on Realty Income as a large, dividend paying real estate investment trust. It is commonly viewed as an income...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

Interiors & More (NSE:INM) has had a rough three months with its share price down 34%. But if you pay close attention...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

With its stock down 29% over the past three months, it is easy to disregard Sahana System (NSE:SAHANA). But if you pay...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Most readers would already be aware that Jeena Sikho Lifecare's (NSE:JSLL) stock increased significantly by 6.3% over...

With a price-to-earnings (or "P/E") ratio of 22.8x Budweiser Brewing Company APAC Limited ( HKG:1876 ) may be sending...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 24x, you may consider Avro...